Invesco Ltd. Biotechnology

Invesco Ltd.

$516 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
RGLS Regulus Therapeutics Inc.	$20M	$47,000 0.0% of portfolio	30,248	Q4 2024 Added 7.06%
XFOR X4 Pharmaceuticals, Inc	$21.3M	$47,000 0.0% of portfolio	62,073	Q4 2024 Reduced 49.85%
APLT Applied Therapeutics Inc.	$27.4M	$45,000 0.0% of portfolio	53,499	Q4 2024 Reduced 90.44%
BMEA Biomea Fusion, Inc.	$84.1M	$45,000 0.0% of portfolio	11,608	Q4 2024 Added 3.73%
VERU Veru Inc.	$41.7M	$42,000 0.0% of portfolio	64,777	Q4 2024 Added 3.47%
PYXS Pyxis Oncology, Inc.	$42.5M	$39,000 0.0% of portfolio	25,366	Q4 2024 Added 19.79%
CVAC Cure Vac N.V.	$542M	$39,000 0.0% of portfolio	11,540	Q4 2024 Added 0.12%
BDTX Black Diamond Therapeutics, Inc.	$64.7M	$38,000 0.0% of portfolio	18,212	Q4 2024 Added 4.19%
MCRB Seres Therapeutics, Inc.	$88.1M	$38,000 0.0% of portfolio	46,577	Q4 2024 Reduced 15.65%
SAVA Cassava Sciences Inc	$114M	$36,000 0.0% of portfolio	15,408	Q4 2024 Reduced 94.97%
IMUX Immunic, Inc.	$35.1M	$36,000 0.0% of portfolio	36,811	Q4 2024 New
ABOS Acumen Pharmaceuticals, Inc.	$48.6M	$34,000 0.0% of portfolio	19,842	Q4 2024 Added 9.09%
ADAP Adaptimmune Therapeutics PLC	$47.4M	$34,000 0.0% of portfolio	63,335	Q4 2024 Added 81.95%
ABCL Ab Cellera Biologics Inc.	$696M	$32,000 0.0% of portfolio	11,253	Q4 2024 Added 2.77%
PRQR Pro Qr Therapeutics N.V.	$118M	$32,000 0.0% of portfolio	11,887	Q4 2024 New
LCTX Lineage Cell Therapeutics, Inc.	$86.6M	$30,000 0.0% of portfolio	61,785	Q4 2024 Added 2.1%
NAUT Nautilus Biotechnology, Inc.	$123M	$30,000 0.0% of portfolio	17,881	Q4 2024 Reduced 13.28%
CABA Cabaletta Bio, Inc.	$50.5M	$29,000 0.0% of portfolio	13,494	Q4 2024 Reduced 2.68%
NKTX Nkarta, Inc.	$73M	$29,000 0.0% of portfolio	11,997	Q4 2024 New
OVID Ovid Therapeutics Inc.	$31.7M	$25,000 0.0% of portfolio	27,207	Q4 2024 Reduced 7.26%
STTK Shattuck Labs, Inc.	$50.9M	$22,000 0.0% of portfolio	18,726	Q4 2024 Added 1.83%
HOWL Werewolf Therapeutics, Inc.	$33.4M	$21,000 0.0% of portfolio	14,589	Q4 2024 Added 6.99%
RAPT Rapt Therapeutics, Inc.	$38.9M	$18,000 0.0% of portfolio	11,510	Q4 2024 Reduced 1.13%
TNYA Tenaya Therapeutics, Inc.	$26.5M	$18,000 0.0% of portfolio	12,876	Q4 2024 Added 15.25%
ATNM Actinium Pharmaceuticals, Inc.	$39M	$15,000 0.0% of portfolio	12,425	Q4 2024 Added 2.13%
GBIO Generation Bio Co.	$29.5M	$15,000 0.0% of portfolio	14,362	Q4 2024 Added 15.7%
ELEV Elevation Oncology, Inc.	$6.99M	$14,000 0.0% of portfolio	24,795	Q4 2024 Added 1.84%
AMRN Amarin Corp Plcuk	$185M	$8,000 0.0% of portfolio	16,769	Q4 2024 Reduced 80.4%
LYRA Lyra Therapeutics, Inc.	$5.73M	$4,000 0.0% of portfolio	23,626	Q4 2024 Added 4.29%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	19,988	Q4 2024 Reduced 84.09%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.